U.S. Diabetes Management Products Market Report

Diabetes affects nearly 24 million people in the U.S. and is the 5th leading cause of death by disease in the U.S. This costs the U.S. healthcare system more than $130 billion per year. To constrain spiraling healthcare costs, the development of more affordable and effective diabetes management (self-testing and treatment) products has become a top priority not only in the U.S., but worldwide. Diabetes management products have become one of the largest medical device and pharmaceutical markets in the U.S., totaling more than $15 billion. As the population of diabetics continues to increase, the market is expected to continue to grow at a double-digit rate over the next five years, reaching nearly $28 billion by 2013. Read on...

Medtech Insight's market intelligence Report A376 thoroughly examines the U.S. markets, competitors, opportunities, and product areas of self-testing blood glucose monitoring systems, continuous blood glucose monitoring systems, insulin therapies, insulin injection devices, insulin pumps, injectable/oral diabetes drugs, and emerging diabetes drugs and technologies, including pancreatic islet cell transplantation.